Artykuły w czasopismach na temat „Bureau of Hospital Reimbursement”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Bureau of Hospital Reimbursement”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
McFarland, Daniel Curtis, Katherine Ornstein i Randall F. Holcombe. "Hospital size and demographics associated with HCAHPS and implications for hospital value-based purchasing (HVBP)." Journal of Clinical Oncology 32, nr 30_suppl (20.10.2014): 38. http://dx.doi.org/10.1200/jco.2014.32.30_suppl.38.
Pełny tekst źródłaPalomäki, A., J. Paltta, L. Pirilä, H. K. Heikkilä, P. Isomäki, J. Huhtakangas, T. Sokka-Isler, O. Kaipiainen-Seppänen i K. Eklund. "AB1251 VALIDITY OF RHEUMATOID ARTHRITIS DIAGNOSES IN FINNISH BIOBANK PATIENTS". Annals of the Rheumatic Diseases 79, Suppl 1 (czerwiec 2020): 1917.1–1917. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3890.
Pełny tekst źródłaXu, Junfang, Xin Wang, Hongying Hao, Jian Wang i Stephen Nicholas. "Impact of hierarchical hospital reform on patients with diabetes in China: a retrospective observational analysis". BMJ Open 11, nr 4 (kwiecień 2021): e041731. http://dx.doi.org/10.1136/bmjopen-2020-041731.
Pełny tekst źródłaDeitelzweig, Steven, Stephen Thompson, Jay Lin, Donna McMorrow i Barbara Johnson. "Impact of CMS VTE Hospital Acquired Conditions (HAC) Policy on Hospital Cost and Revenue Associated with Major Surgical Hip and Knee Procedures." Blood 116, nr 21 (19.11.2010): 3824. http://dx.doi.org/10.1182/blood.v116.21.3824.3824.
Pełny tekst źródłaÁlvarez Roman, Teresa, Elena Monzón Manzano, Ihosvany Fernandez-Bello, Mónica Martín, María Isabel Rivas Pollmar, Raul Justo Sanz, Sara García Barcenilla i in. "Real Life Experience in Clinical Practice with Recombinant Coagulation FVIII-Fc Fusion Protein". Blood 134, Supplement_1 (13.11.2019): 4929. http://dx.doi.org/10.1182/blood-2019-127878.
Pełny tekst źródłaPalomäki, A., T. Laitinen, J. Koskela, A. Palotie i N. Mars. "OP0007 MUC5B PROMOTER VARIANT AND LONG-TERM INCIDENCE OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POPULATION BIOBANK STUDY OF 250,000 INDIVIDUALS". Annals of the Rheumatic Diseases 80, Suppl 1 (19.05.2021): 4.2–4. http://dx.doi.org/10.1136/annrheumdis-2021-eular.619.
Pełny tekst źródłaKoschmieder, Steffen, Susanne Isfort, Dominik Wolf, Florian H. Heidel, Philippe Schafhausen, Martin Griesshammer, Denise Wolleschak i in. "Ruxolitinib Shows Efficacy in Patients with Newly-Diagnosed Polycythemia Vera: Futility Analysis of the Randomized Ruxo-BEAT Clinical Trial of the German Study Group for Myeloproliferative Neoplasms". Blood 134, Supplement_1 (13.11.2019): 2944. http://dx.doi.org/10.1182/blood-2019-123985.
Pełny tekst źródłaDunavin, Neil, Lih-Wen Mau, Christa Lea Meyer, Clint Divine, Al-Ola Abdallah, Susan Leppke, Anita D'Souza i in. "Health Care Reimbursement and Service Utilization Among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings". Blood 132, Supplement 1 (29.11.2018): 832. http://dx.doi.org/10.1182/blood-2018-99-118423.
Pełny tekst źródłaMeunier, Godelieve, Loïc Ysebaert, Phi Linh Nguyen-Thi, Stephane Lepretre, Anne Quinquenel, Jehan Dupuis, Richard Lemal i in. "First Line Chronic Lymphocytic Leukemia Immunochemotherapy for the Elderly Patients over 79 Years Is Feasible, and Achieves Good Results: A Filo Retrospective Study". Blood 126, nr 23 (3.12.2015): 4170. http://dx.doi.org/10.1182/blood.v126.23.4170.4170.
Pełny tekst źródłaMonzón Manzano, Elena, Ihosvany Fernandez-Bello, Raul Justo Sanz, Larissa Valor, Francisco Javier López-Longo, Angel Robles, Teresa Álvarez Roman, Miguel A. Canales, Victor Jimenez-Yuste i Nora Butta. "Prothrombotic State, Platelet Activation and Netosis in Systemic Lupus Erythematosus". Blood 134, Supplement_1 (13.11.2019): 1141. http://dx.doi.org/10.1182/blood-2019-127991.
Pełny tekst źródłaSchlenk, Richard F., Stefan Schönsteiner, Katharina Krempel, Anja Neumann, Walter Fiedler, Peter Brossart, Bernd Hertenstein i in. "Cost-Effectiveness Analysis of Arsenic Trioxide in Combination with All-Trans Retinoic Acid in Acute Promyelocytic Leukemia with Pretreatment White Blood Counts <10G/L". Blood 124, nr 21 (6.12.2014): 2636. http://dx.doi.org/10.1182/blood.v124.21.2636.2636.
Pełny tekst źródłaMcGuirk, Joseph P., Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang i Genovefa A. Papanicolaou. "Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation". Blood 136, Supplement 1 (5.11.2020): 42–43. http://dx.doi.org/10.1182/blood-2020-133799.
Pełny tekst źródłaKaufman, Brystana, Diane Holland, Catherine Vanderboom, Cory Ingram, Alice Chun, Erica Langan, Henry Baer-Benson i Joan Griffin. "EVALUATING IMPLEMENTATION COSTS FOR A TRANSITIONAL PALLIATIVE CARE INTERVENTION TO SUPPORT RURAL CAREGIVERS". Innovation in Aging 6, Supplement_1 (1.11.2022): 213. http://dx.doi.org/10.1093/geroni/igac059.850.
Pełny tekst źródłaLai, Sheng Jie, T. Wangteeraprasert, T. Sermkaew, O. Nararak, S. Binsard, M. Phanawadee, I. Ieowongjaroen i in. "Evaluation of Three Main Tuberculosis Case Reporting Systems in Satun Province, Thailand, 2011". Outbreak, Surveillance, Investigation & Response (OSIR) Journal 7, nr 3 (29.09.2014): 16–23. http://dx.doi.org/10.59096/osir.v7i3.263288.
Pełny tekst źródłaByrne, Jenny, Joanne Ewing, Adam J. Mead, Heather Oakervee, Gavin Campbell, Ian Amott, Andrew Goringe i in. "Sequence of Second Generation Tyrosine Kinase Inhibitors (TKIs) in the Treatment of Patients with Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia - Real World Experience in the UK". Blood 134, Supplement_1 (13.11.2019): 3434. http://dx.doi.org/10.1182/blood-2019-122893.
Pełny tekst źródłaMcBride, Ali, i Daniel O. Persky. "Impact of Treatment Sequencing on Outcomes and Costs in Relapsed Follicular or Other Low Grade B-Cell Non-Hodgkin Lymphoma - Results of an Evidence-Based Budget Impact Model". Blood 136, Supplement 1 (5.11.2020): 14–15. http://dx.doi.org/10.1182/blood-2020-141748.
Pełny tekst źródłaXie, Jing, Alan Yong, Catherine Waweru, Thuy Anh Sorof, Ravi K. Goyal, Keith L. Davis, George Follows i Peter Hillmen. "Real-World Treatment Patterns and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in the UK: A Preliminary Analysis". Blood 134, Supplement_1 (13.11.2019): 5885. http://dx.doi.org/10.1182/blood-2019-123025.
Pełny tekst źródłaShi, Jianwei, Rui Liu, Hua Jiang, Chunxu Wang, Yue Xiao, Nana Liu, Zhaoxin Wang i Leiyu Shi. "Moving towards a better path? A mixed-method examination of China’s reforms to remedy medical corruption from pharmaceutical firms". BMJ Open 8, nr 2 (luty 2018): e018513. http://dx.doi.org/10.1136/bmjopen-2017-018513.
Pełny tekst źródłaSharman, Jeff P., John M. Burke, Habte A. Yimer, Michael A. Boxer, Sunil Babu, Jia Li, Yong Mun i Alexey Danilov. "Final Results from the Multicenter, Open-Label, Phase II GIBB Study of Obinutuzumab+Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia". Blood 134, Supplement_1 (13.11.2019): 4317. http://dx.doi.org/10.1182/blood-2019-122482.
Pełny tekst źródłaAbe, M. A. "Hospital Reimbursement Schemes". Medical Care 23, nr 9 (wrzesień 1985): 1055–66. http://dx.doi.org/10.1097/00005650-198509000-00004.
Pełny tekst źródłaFoulon, Stephanie, Pascale Cony-Makhoul, Agnes Guerci-Bresler, Marc Delord, Eric Solary, Alain Monnereau, Julia Bonastre i Pascale Tubert Bitter. "Using Healthcare Claims Data to Analyze the Prevalence of Chronic Myeloid Leukemia in France: A Nationwide Population-Based Study". Blood 132, Supplement 1 (29.11.2018): 3015. http://dx.doi.org/10.1182/blood-2018-99-111489.
Pełny tekst źródłaWelton, John M., i Kathy Harris. "Hospital Billing and Reimbursement". JONA: The Journal of Nursing Administration 37, nr 4 (kwiecień 2007): 164–66. http://dx.doi.org/10.1097/01.nna.0000266846.77178.23.
Pełny tekst źródła&NA;. "Changes in Hospital Reimbursement". Obstetric Anesthesia Digest 10, nr 3 (październik 1990): 123. http://dx.doi.org/10.1097/00132582-199010000-00002.
Pełny tekst źródłaBegum, J., i M. Nisar. "POS1200-HPR IL-17 OR TNF INHIBITORS - REAL WORLD IMPACT OF SHARED DECISION MAKING IN A NURSE LED BIOLOGICS SERVICE". Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 932.2–933. http://dx.doi.org/10.1136/annrheumdis-2023-eular.920.
Pełny tekst źródłaChanan-Khan, Asher, Paula Cramer, Fatih Demirkan, Graeme Fraser, Rodrigo Santucci Silva, Halyna Pylypenko, Sebastian Grosicki i in. "Insights into the Management of Adverse Events in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Experience from the Phase 3 HELIOS Study of Ibrutinib Combined with Bendamustine/Rituximab". Blood 126, nr 23 (3.12.2015): 2936. http://dx.doi.org/10.1182/blood.v126.23.2936.2936.
Pełny tekst źródłaCramer, Paula, Asher Chanan-Khan, Graeme Fraser, Fatih Demirkan, Rodrigo Santucci Silva, Halyna Pylypenko, Sebastian Grosicki i in. "Improvement of Quality of Response with Ibrutinib Plus Bendamustine/Rituximab Vs Placebo Plus Bendamustine/Rituximab for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)". Blood 126, nr 23 (3.12.2015): 2938. http://dx.doi.org/10.1182/blood.v126.23.2938.2938.
Pełny tekst źródłaBunker, J. P., i R. W. Schaffarzick. "Reimbursement Incentives for Hospital Care". Annual Review of Public Health 7, nr 1 (maj 1986): 391–409. http://dx.doi.org/10.1146/annurev.pu.07.050186.002135.
Pełny tekst źródłaHui, Clayton, Haroon Kisana, John R. Martin, Chad Stecher i Joshua Hustedt. "Trends in Medicare Physician and Facility Fee Reimbursement in Orthopaedic Foot and Ankle". Foot & Ankle Orthopaedics 7, nr 1 (styczeń 2022): 2473011421S0025. http://dx.doi.org/10.1177/2473011421s00254.
Pełny tekst źródłaCurtiss, Frederic R., i Beverly L. Black. "Reimbursement considerations about hospital outpatient dispensing". American Journal of Health-System Pharmacy 42, nr 5 (1.05.1985): 1046–48. http://dx.doi.org/10.1093/ajhp/42.5.1046a.
Pełny tekst źródłaWang, Chan, i You-hua Chen. "Reimbursement and hospital competition in China". Economic Research-Ekonomska Istraživanja 30, nr 1 (styczeń 2017): 1209–23. http://dx.doi.org/10.1080/1331677x.2017.1340177.
Pełny tekst źródłaMcClellan, Mark. "Hospital Reimbursement Incentives: An Empirical Analysis". Journal of Economics & Management Strategy 6, nr 1 (1.03.1997): 91–128. http://dx.doi.org/10.1162/105864097567048.
Pełny tekst źródłaMcClellan, Mark. "Hospital Reimbursement Incentives: An Empirical Analysis". Journal of Economics Management Strategy 6, nr 1 (marzec 1997): 91–128. http://dx.doi.org/10.1111/j.1430-9134.1997.00091.x.
Pełny tekst źródłaLinton, O. W. "Medicare amendments change teaching hospital reimbursement." Radiology 161, nr 2 (listopad 1986): 567–68. http://dx.doi.org/10.1148/radiology.161.2.3532198.
Pełny tekst źródłaPalley, Michael A. "Hospital information systems and DRG reimbursement". Information & Management 20, nr 3 (marzec 1991): 227–34. http://dx.doi.org/10.1016/0378-7206(91)90057-9.
Pełny tekst źródłaHarris, Burton H., Kathryn Dirkes Bass i Mary D. O'Brien. "Hospital reimbursement for pediatric trauma care". Journal of Pediatric Surgery 31, nr 1 (styczeń 1996): 78–81. http://dx.doi.org/10.1016/s0022-3468(96)90323-1.
Pełny tekst źródłaSeldon, James R. "Hospital cost-shifting under fractional reimbursement". Atlantic Economic Journal 14, nr 1 (marzec 1986): 50–58. http://dx.doi.org/10.1007/bf02303510.
Pełny tekst źródłaStoffel, Victoria, Justin M. Camacho, Connor Heeb, Saishi Cui, Jalene Y. Shim, Salvatore J. Pacella, Amanda A. Gosman i Chris M. Reid. "Unveiling the Hidden Discrepancies Between Medicare Physician Reimbursement Rates and Inflation Across Different Surgical Specialties". Annals of Plastic Surgery 92, nr 5S (maj 2024): S340—S344. http://dx.doi.org/10.1097/sap.0000000000003806.
Pełny tekst źródłaWolf, Sarah, Ingrid Zechmeister-Koss, Nicole Grössmann i Claudia Wild. "Evaluating options for decision making on costly hospital drugs in Austria". International Journal of Technology Assessment in Health Care 36, nr 3 (14.05.2020): 277–84. http://dx.doi.org/10.1017/s0266462320000276.
Pełny tekst źródłaSinzobahamvya, Nicodème, Thorsten Kopp, Claudia Arenz, Hedwig C. Blaschczok, Viktor Hraska i Boulos Asfour. "Reimbursement by current German Diagnosis-Related Groups system penalises complex congenital heart surgery". Cardiology in the Young 24, nr 2 (13.05.2013): 344–50. http://dx.doi.org/10.1017/s1047951113000437.
Pełny tekst źródłaMerritt-Myrick, Samirah, i David Harris III. "Successful Billing Strategies in the Hospital Industry". International Journal of Human Resource Studies 11, nr 1 (15.01.2020): 85. http://dx.doi.org/10.5296/ijhrs.v11i1.18212.
Pełny tekst źródłaDonovan, Melissa J., Daniel E. Ramirez, Gregory D. Crenshaw, Taylor A. Smith, Hernan A. Bazan i W. Charles Sternbergh. "Hospital Reimbursement for Carotid Stenting and Endarterectomy". Journal of Endovascular Therapy 21, nr 2 (kwiecień 2014): 296–302. http://dx.doi.org/10.1583/13-4549.1.
Pełny tekst źródłaDegrassat-Théas, A., M. Bensadon, C. Rieu, M. Angalakuditi, C. Le Pen i P. Paubel. "Hospital Reimbursement Price Cap for Cancer Drugs". PharmacoEconomics 30, nr 7 (lipiec 2012): 565–73. http://dx.doi.org/10.2165/11588320-000000000-00000.
Pełny tekst źródłaSederer, Lloyd I., Susan V. Eisen, Diana Dill, Mollie C. Grob, Michele L. Gougeon i Steven M. Mirin. "Case-Based Reimbursement for Psychiatric Hospital Care". Psychiatric Services 43, nr 11 (listopad 1992): 1120–26. http://dx.doi.org/10.1176/ps.43.11.1120.
Pełny tekst źródłaBowers, Mary Lou. "A Reimbursement Primer for Hospital Oncology Programs". Oncology Issues 19, nr 3 (maj 2004): 41–44. http://dx.doi.org/10.1080/10463356.2004.11883195.
Pełny tekst źródłaPope, Gregory C. "Hospital nonprice competition and medicare reimbursement policy". Journal of Health Economics 8, nr 2 (czerwiec 1989): 147–72. http://dx.doi.org/10.1016/0167-6296(89)90001-5.
Pełny tekst źródłaRodrigues, Jose. "Hospital utilization and reimbursement method in Brazil". International Journal of Health Planning and Management 4, nr 1 (styczeń 1989): 3–15. http://dx.doi.org/10.1002/hpm.4740040103.
Pełny tekst źródłaMilcent, Carine. "Hospital ownership, reimbursement systems and mortality rates". Health Economics 14, nr 11 (2005): 1151–68. http://dx.doi.org/10.1002/hec.1010.
Pełny tekst źródłaWolf, Sarah, i Claudia Wild. "PP87 Inpatient Drug Reimbursement: Approaches For A Democratic Process". International Journal of Technology Assessment in Health Care 35, S1 (2019): 54–55. http://dx.doi.org/10.1017/s0266462319002289.
Pełny tekst źródłaSmith, Brian S., Walter S. Schroeder i Gary R. Tataronis. "Hospital Reimbursement for Adult Patients with Severe Sepsis Treated with Drotrecogin Alfa (Activated)". Hospital Pharmacy 40, nr 2 (luty 2005): 146–53. http://dx.doi.org/10.1177/001857870504000206.
Pełny tekst źródłaGoetz, Gregor, Dimitra Panteli, Reinhard Busse i Claudia Wild. "PP112 Reimbursement Decisions for Medical Services in Austria: An Analysis of Influencing Factors for the Hospital Individual Services Catalogue". International Journal of Technology Assessment in Health Care 38, S1 (grudzień 2022): S77. http://dx.doi.org/10.1017/s0266462322002355.
Pełny tekst źródła